Study #2018-0345
A Personalized Vaccine for the Immune Prevention of Multiple Myeloma
MD Anderson Study Status
Not Accepting
Treatment Agent
Vaccine Therapy, Lenalidomide
Description
This early phase I trial studies the side effects of personalized vaccine in treating patients with smoldering multiple myeloma. Vaccines made from a person's blood and bone marrow may help the body build an effective immune response to kill cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Smoldering Plasma Cell Myeloma
Study phase:
Phase I (Early)
Physician name:
Krina Patel
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.